We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Celiac Disease Blood Test to Eliminate Painful Biopsies

By LabMedica International staff writers
Posted on 21 Sep 2023
Print article
Image: Biopsy-free diagnosis of celiac disease in adults has shown promising results (Photo courtesy of Freepik)
Image: Biopsy-free diagnosis of celiac disease in adults has shown promising results (Photo courtesy of Freepik)

There is still a controversy over whether it is possible to diagnose celiac disease in adults using only serology. Now, a study has found that a simple test for measuring the levels of anti-tissue transglutaminase IgA (tTG-IgA) in the blood could be used as a diagnostic threshold in predicting duodenal villous atrophy, a key feature of celiac disease.

Researchers from the University of Salerno (Fisciano SA, Italy) conducted a study on a cohort of individuals suspected to have celiac disease. After certain exclusions, the final cohort included 436 individuals, comprising 296 women and 140 men, with an average age of 40. These participants hailed from various global regions, mostly Europe, followed by Asia, Oceania, and South America.

Based on their symptoms, the participants were divided into three categories: those showing classical symptoms like anemia, weight loss, or diarrhea; those with atypical symptoms; and those who were suspected to have celiac disease based on family history or other associated autoimmune conditions. Duodenal tissue samples were collected from the participants via endoscopy and were assessed by local pathologists at 14 different sites. Additionally, tTG-IgA levels were measured in both local and central labs. A result was considered positive if tTG-IgA levels exceeded one time the upper limit of normal (ULN).

Out of the cohort, 363 participants (or 83%) had tTG-IgA levels above the threshold, while 73 (or 17%) had levels below it. Among those with elevated tTG-IgA, 341 were confirmed to have celiac disease through histological review, whereas 22 did not have the disease. Of the participants with low tTG-IgA, seven were false negatives with positive histology, and 66 were true negatives. Importantly, the study found that tTG-IgA concentrations that were 5, 10, or 15 times higher than the ULN offered the most reliable diagnostic accuracy, suggesting that 10 times the ULN could be a useful diagnostic threshold. This study validates the use of a blood test for diagnosing celiac disease in adults, similar to the "no-biopsy" approach currently used in children. The detailed findings of the study were published in The Lancet Gastroenterology & Hepatology.

Related Links:
University of Salerno

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Unit-Dose Packaging solution
HLX
New
Respiratory Syncytial Virus Test
QuickVue RSV Test
New
Human Papillomavirus Multiplex Assay
Anyplex Ⅱ HPV28 Detection

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Immunology

view channel
Image: Bone marrow affected by multiple myeloma, a disease against which PVR inhibition can increase the efficacy of immunotherapy (Photo courtesy of Cancer Epigenetics Group, IJC)

Epigenetic Test Could Determine Efficacy of New Immunotherapy Treatments Against Multiple Myeloma

Multiple myeloma is a blood cancer that primarily affects individuals over the age of sixty, and its occurrence rises as the population ages. In this disease, the bone marrow—the spongy tissue inside bones... Read more

Microbiology

view channel
Image: New research promises a potential non-invasive stool test and novel therapy for endometriosis (Photo courtesy of Shutterstock)

Non-Invasive Stool Test to Diagnose Endometriosis and Help Reduce Disease Progression

Endometriosis, a painful condition impacting nearly 200 million women globally, occurs when tissue similar to the lining of the uterus grows outside its usual location, such as on the intestines or the... Read more

Pathology

view channel
Image: A glioblastoma tumor cell (green) present in the white matter (blue) near a blood vessel (red), visualized via the novel three-photon microscopy workflow Deep3P (Photo courtesy of EMBL/Heidelberg University)

Pioneering Microscopy Technique Improves Diagnosis of Glioblastoma Brain Tumors

Along the brain’s largest nerve fiber highway, known as the corpus callosum, travel cells that form one of the most lethal brain cancers, glioblastomas. Now, scientists have developed a cellular detector... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.